Lithium Chloride

12/03/2014 - "The widely used mood stabilizer lithium chloride prevented NIFAR in a time-dependent and dose-dependent manner, consistent with its known efficacy in treating bipolar disorder. "
01/01/2014 - "Lithium chloride (LiCl) is an FDA-approved drug for bipolar disorder. "
04/01/2013 - "Lithium chloride (LiCl) is a drug used to treat bipolar disorder, but has side effects in the female reproductive system. "
03/01/2001 - "Lithium chloride, a compound with clinical use in bipolar disorder, produces adverse effects on ovarian function in amphibian and rodent models. "
03/01/1995 - "Lithium chloride, one of the first drugs used in the treatment of mania, has become one of the most important agents utilized for the treatment of manic-depression and many schizoeffective disorders. "

03/01/2015 - "Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model."
11/01/2015 - "These results indicated that lithium chloride could be a potential antiviral drug for curing dogs with canine parvovirus infection. "
11/01/2015 - "Antiviral effect of lithium chloride on infection of cells by canine parvovirus."
09/01/2015 - "We have also previously shown that lithium chloride (LiCl), a GSK3 inhibitor suppressed development of Plasmodium berghei in a murine model of malarial infection. "
04/01/2015 - "Antiviral effect of lithium chloride on infection of cells by porcine parvovirus."

06/01/2015 - "Protective effects of lithium chloride on seizure susceptibility: Involvement of α2-adrenoceptor."
09/01/2011 - "In our study, acute administration of a single effective dose of lithium chloride (30 mg/kg, i.p.) increased the seizure threshold. "
06/01/2015 - "In summary, our findings demonstrated that α2-adrenoceptor pathway could be involved in the anticonvulsant properties of lithium chloride in the model of chemically induced clonic seizure. "
06/01/2015 - "Injection of a single effective dose of lithium chloride (30mg/kg, i.p.) significantly increased the seizure threshold (p<0.01). "
05/01/2010 - "Injection of a single effective dose of lithium chloride (25 mg/kg) intraperitoneally (i.p.) increased significantly the seizure threshold (P<0.01). "

02/01/2015 - "A 24 h lithium chloride (20 mg/kg body weight) challenge determined that serum lithium chloride increased within 2 h and cleared the system within 24 h, demonstrating the effective delivery of lithium chloride. "
02/01/2015 - "Treatment did not influence body weight (P≥0.20) or feed intake (P≥0.81), demonstrating that lithium chloride did not negatively affect broiler growth. "
02/01/2015 - "Beginning at 1 or 3 wk of age, chickens were administered lithium chloride (20 mg/kg body weight) or water daily by oral gavage. "
07/30/2006 - "The present experiment compared the strengths of taste aversion learning in rats induced by forced swimming in a water pool (5, 15, 30, or 60 min), voluntary running in an activity wheel (15, 30, 60, or 120 min), forced running in a motorized wheel (60 min at the speed of 8 m/min), optional running in the apparatus consisting of an activity wheel and a side room (120 min), and a lithium chloride (LiCl, 0.15 M LiCl at 2% of body weight) injection. "
01/01/2002 - "injection of 0.15 M LiCl (lithium chloride) (2 ml/100 g body weight). "

06/14/2012 - "We show that miR-371-373 expression is induced by lithium chloride and is positively correlated with Wnt/β-catenin-signaling activity in several human cancer cell lines. "
01/01/2014 - "Additionally, lithium chloride-treated SKOV3 xenograft mice had a significant reduction in tumor growth compared with control-treated animals. "
01/01/2010 - "In this study, we investigated whether the Wnt pathway activator lithium chloride (LiCl) regulates proliferation of retinoblastoma cancer stem-like cells. "
01/01/2010 - "Therefore, based on these findings, we have undertaken a clinical trial of lithium chloride in the treatment of patients with unresectable carcinoid cancer."
03/01/2008 - "Lithium chloride (LiCl) treatment activated Wnt signaling in osteoblasts, inhibited myeloma bone disease, and decreased tumor burden in bone, but increased tumor growth when 5TGM1 cells were inoculated subcutaneously. "